BioLineRx (BLRX) Tops Q2 EPS by 12c
BioLineRx (NASDAQ: BLRX) reported Q2 EPS of ($0.01), $0.12 better than the analyst estimate of ($0.13).
For earnings history and earnings-related data on BioLineRx (BLRX) click here.
BioLineRx (NASDAQ: BLRX) reported Q2 EPS of ($0.01), $0.12 better than the analyst estimate of ($0.13).
For earnings history and earnings-related data on BioLineRx (BLRX) click here.